Inflammation markers and prediction of post-stroke vascular disease recurrence: The MITICO study
- 27 February 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Zeitschrift für Neurologie
- Vol. 256 (2), 217-224
- https://doi.org/10.1007/s00415-009-0058-4
Abstract
Vascular disease recurrence following stroke is the main cause of morbidity and mortality. The MITICO study was designed to assess the prognostic value of markers of inflammation in relation to the risk of recurrence of vascular disease. Multi-centered prospective observational study, in patients with ischemic stroke not receiving anti-coagulation therapy and who were recruited within 1–3 months from stroke onset. Blood samples were obtained at baseline and follow- up for the determination of high-sensitive C reactive protein (CRP), IL-6, IL-10, ICAM-1, VCAM- 1, MMP-9 and cellular fibronectin. Four follow-up visits within the first year were to rule out recurrence. Of 965 patients from 65 hospitals, 780 (aged 67.5±11.2 years, 33.6 % female) were valid for main analysis. One-hundred and three patients (13.2 %) had a new adverse vascular event and 116 patients (14.9 %) a vascular event or vascular death (66.4 % stroke, 21.5 % coronary and 12.1 % peripheral). Levels of IL-6 > 5 pg/mL and VCAM-1 > 1350 ng/mL (ROC curve analyses) were associated with vascular disease recurrence risk (OR: 28.7; 95 % CI: 14.2–58.0 vs. OR: 4.1; 95 % CI: 2.4–7.1, respectively) following adjustment for confounding variables. Risk of adverse vascular event or death from vascular disease were associated with IL-6 (OR: 21.2; 95 % CI: 11.6–38.7) and VCAM-1 (OR: 3.8; 95 % CI: 2.3–6.4). Baseline values of IL-6 > 5 pg/mL and VCAM-1 > 1350 ng/mL increase 21-fold and 4-fold, respectively, the risk of new vascular disease event or death from vascular disease in patients with ischemic stroke not receiving anti-coagulation treatment.Keywords
This publication has 39 references indexed in Scilit:
- Inflammation and StrokeStroke, 2007
- Mineralocorticoid Receptor Activation Causes Cerebral Vessel Remodeling and Exacerbates the Damage Caused by Cerebral IschemiaHypertension, 2006
- The Harms and Benefits of Inflammatory and Immune Responses in Vascular DiseaseStroke, 2006
- Cause of Stroke Recurrence Is MultifactorialStroke, 2003
- Poor Outcome After First-Ever StrokeStroke, 2003
- Changes in Stroke Mortality Rates for 1950 to 1997Stroke, 2001
- Risk Factors for Early Recurrence After Ischemic StrokeStroke, 1998
- Three-Year Survival and Recurrence After Stroke in Malmö, SwedenStroke, 1998
- Stroke trends in an aging population. The Technology Assessment Methods Project Team.Stroke, 1993
- Determinants of early recurrence of cerebral infarction. The Stroke Data Bank.Stroke, 1989